David J. Stone

Vice President, Genetics And Target Identification at Cerevel Therapeutics

David J. Stone has extensive work experience in the field of genetics and neuroscience. David J. is currently the Vice President of Genetics and Target Identification at Cerevel Therapeutics, a role they have held since April 2022. Prior to this, they were the Head of Genetics at the same company from July 2019 to April 2022.

Before joining Cerevel Therapeutics, Stone worked at Merck for a significant portion of their career. David J. held various positions at Merck, including Director of Neurogenetics from December 2013 to July 2019 and Director of Genetics from April 2011 to December 2013. In these roles, they were responsible for leading genetic target discovery and validation efforts in the neuroscience therapeutic areas. David J. also collaborated with other organizations and played a key role in pharmacogenetic plans for clinical trials.

Stone's career at Merck began in 2003, where they initially served as a Research Fellow and led a team in conducting the first genome-wide siRNA screen. David J. later became the Director of Molecular Profiling Neuroscience, overseeing objectives related to molecular profiling, biomarker development, and genetic studies in the Neuroscience Franchise.

Earlier in their career, Stone worked as a Project Leader at CuraGen Corporation, leading a team in developing high-throughput assays for small molecule targets in neuroscience. David J. also co-chaired a team that developed a platform to predict drug action based on genomic expression profiles.

Stone's academic background includes serving as an Instructor in the Department of Psychiatry at Harvard Medical School and as a Postdoc in Neurobiology at the University of Southern California. During their time at USC, they made significant contributions to the field, including developing a surgery technique and establishing a functional link between estrogen and apoE in mRNA expression.

Overall, David J. Stone's work experience demonstrates their expertise in genetics, target identification, molecular profiling, and neuroscience.

David J. Stone completed their education in a chronological order. David J. began their academic journey at Saint Vincent College, where they earned a Bachelor of Science degree in Biology from 1985 to 1989. Following this, they pursued further studies at the University of Pittsburgh, completing a Master's degree in Education from 1990 to 1991. David J. continued their education at the same institution, undertaking a PhD in Anthropology and Population Genetics, which they successfully completed from 1991 to 1995.

Links

Previous companies

Merck logo
University of Southern California logo

Timeline

  • Vice President, Genetics And Target Identification

    April, 2022 - present

  • Head Of Genetics

    July, 2019

View in org chart